AIDS: A Justifiable Share
Jon Cohen
Lobby groups pushing for more funding for research on specific diseases often compare their share of the National Institutes of Health's (NIH's) budget to the $1.5 billion being spent on AIDS. But NIH officials counter that the spending on AIDS is justified on the basis of the impact of the disease, scientific opportunities, and the chance to reduce expenditures on AIDS in the long term, as has happened with many other infectious diseases.